APO Research
Talk to an analyst

APO RESEARCH · REPORT

Multivalent Oral Rotavirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Multivalent Oral Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025178 pages

Choose your research edition.

Industry ResearchMultivalent Oral Rotavirus Vaccine Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Multivalent Oral Rotavirus Vaccine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Multivalent Oral Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multivalent Oral Rotavirus Vaccine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Multivalent Oral Rotavirus Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Multivalent Oral Rotavirus Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Multivalent Oral Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Multivalent Oral Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Multivalent Oral Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Multivalent Oral Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Multivalent Oral Rotavirus Vaccine include Serum Institute of India, Lanzhou Institute of Biological Products and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Multivalent Oral Rotavirus Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Multivalent Oral Rotavirus Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Multivalent Oral Rotavirus Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Multivalent Oral Rotavirus Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Multivalent Oral Rotavirus Vaccine Segment by Company

Serum Institute of India

Lanzhou Institute of Biological Products

Merck

Multivalent Oral Rotavirus Vaccine Segment by Type

RV3

RV5

Multivalent Oral Rotavirus Vaccine Segment by Application

Government Institution

Private Sector

Other

Multivalent Oral Rotavirus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multivalent Oral Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multivalent Oral Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multivalent Oral Rotavirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Multivalent Oral Rotavirus Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Multivalent Oral Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Multivalent Oral Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Multivalent Oral Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Multivalent Oral Rotavirus Vaccine Industry Trends Table 2. Multivalent Oral Rotavirus Vaccine Industry Drivers Table 3. Multivalent Oral Rotavirus Vaccine Industry Opportunities and Challenges Table 4. Multivalent Oral Rotavirus Vaccine Industry Restraints Table 5. Global Multivalent Oral Rotavirus Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Multivalent Oral Rotavirus Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Manufacturers Table 9. Global Multivalent Oral Rotavirus Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Multivalent Oral Rotavirus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Multivalent Oral Rotavirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Multivalent Oral Rotavirus Vaccine Manufacturers, Product Type & Application Table 13. Global Multivalent Oral Rotavirus Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Multivalent Oral Rotavirus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of RV3 Table 17. Major Manufacturers of RV5 Table 18. Global Multivalent Oral Rotavirus Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Multivalent Oral Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Multivalent Oral Rotavirus Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Multivalent Oral Rotavirus Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Multivalent Oral Rotavirus Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Government Institution Table 29. Major Manufacturers of Private Sector Table 30. Major Manufacturers of Other Table 31. Global Multivalent Oral Rotavirus Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 33. Global Multivalent Oral Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 34. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Multivalent Oral Rotavirus Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Multivalent Oral Rotavirus Vaccine Revenue by Application (2021-2026) & (K Units) Table 38. Global Multivalent Oral Rotavirus Vaccine Revenue by Application (2027-2032) & (K Units) Table 39. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Multivalent Oral Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Multivalent Oral Rotavirus Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Multivalent Oral Rotavirus Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Multivalent Oral Rotavirus Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Multivalent Oral Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 48. North America Multivalent Oral Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 49. Europe Multivalent Oral Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 51. Europe Multivalent Oral Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Multivalent Oral Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Multivalent Oral Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 58. Global Multivalent Oral Rotavirus Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Multivalent Oral Rotavirus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Multivalent Oral Rotavirus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Region (2027-2032) Table 63. Serum Institute of India Company Information Table 64. Serum Institute of India Business Overview Table 65. Serum Institute of India Multivalent Oral Rotavirus Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Serum Institute of India Multivalent Oral Rotavirus Vaccine Product Portfolio Table 67. Serum Institute of India Recent Development Table 68. Lanzhou Institute of Biological Products Company Information Table 69. Lanzhou Institute of Biological Products Business Overview Table 70. Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Product Portfolio Table 72. Lanzhou Institute of Biological Products Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Multivalent Oral Rotavirus Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck Multivalent Oral Rotavirus Vaccine Product Portfolio Table 77. Merck Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Multivalent Oral Rotavirus Vaccine Distributors List Table 81. Multivalent Oral Rotavirus Vaccine Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Multivalent Oral Rotavirus Vaccine Product Image Figure 2. Global Multivalent Oral Rotavirus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Multivalent Oral Rotavirus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Multivalent Oral Rotavirus Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Multivalent Oral Rotavirus Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Multivalent Oral Rotavirus Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. RV3 Image Figure 9. RV5 Image Figure 10. Global Multivalent Oral Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Multivalent Oral Rotavirus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Multivalent Oral Rotavirus Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Government Institution Image Figure 17. Private Sector Image Figure 18. Other Image Figure 19. Global Multivalent Oral Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Multivalent Oral Rotavirus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Multivalent Oral Rotavirus Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Multivalent Oral Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Multivalent Oral Rotavirus Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Multivalent Oral Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Multivalent Oral Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Multivalent Oral Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Multivalent Oral Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Multivalent Oral Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Multivalent Oral Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Multivalent Oral Rotavirus Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Multivalent Oral Rotavirus Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • RV3
  • RV5
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • Serum Institute of India
  • Lanzhou Institute of Biological Products
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Multivalent Oral Rotavirus Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Multivalent Oral Rotavirus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Multivalent Oral Rotavirus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Multivalent Oral Rotavirus Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Multivalent Oral Rotavirus Vaccine Market Dynamics
  1. 2.1 Multivalent Oral Rotavirus Vaccine Industry Trends
  2. 2.2 Multivalent Oral Rotavirus Vaccine Industry Drivers
  3. 2.3 Multivalent Oral Rotavirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Multivalent Oral Rotavirus Vaccine Industry Restraints
3 Multivalent Oral Rotavirus Vaccine Market by Manufacturers
  1. 3.1 Global Multivalent Oral Rotavirus Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Multivalent Oral Rotavirus Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Multivalent Oral Rotavirus Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Multivalent Oral Rotavirus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Multivalent Oral Rotavirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Multivalent Oral Rotavirus Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Multivalent Oral Rotavirus Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Multivalent Oral Rotavirus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Multivalent Oral Rotavirus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Multivalent Oral Rotavirus Vaccine Tier 1, Tier 2, and Tier 3
4 Multivalent Oral Rotavirus Vaccine Market by Type
  1. 4.1 Multivalent Oral Rotavirus Vaccine Type Introduction
  2. 4.1.1 RV3
  3. 4.1.2 RV5
  4. 4.2 Global Multivalent Oral Rotavirus Vaccine Sales by Type
  5. 4.2.1 Global Multivalent Oral Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Multivalent Oral Rotavirus Vaccine Revenue by Type
  9. 4.3.1 Global Multivalent Oral Rotavirus Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Multivalent Oral Rotavirus Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2021-2032)
5 Multivalent Oral Rotavirus Vaccine Market by Application
  1. 5.1 Multivalent Oral Rotavirus Vaccine Application Introduction
  2. 5.1.1 Government Institution
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Multivalent Oral Rotavirus Vaccine Sales by Application
  6. 5.2.1 Global Multivalent Oral Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Multivalent Oral Rotavirus Vaccine Revenue by Application
  10. 5.3.1 Global Multivalent Oral Rotavirus Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Multivalent Oral Rotavirus Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application (2021-2032)
6 Global Multivalent Oral Rotavirus Vaccine Sales by Region
  1. 6.1 Global Multivalent Oral Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Multivalent Oral Rotavirus Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Multivalent Oral Rotavirus Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Multivalent Oral Rotavirus Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Multivalent Oral Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Multivalent Oral Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Multivalent Oral Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Multivalent Oral Rotavirus Vaccine Revenue by Region
  1. 7.1 Global Multivalent Oral Rotavirus Vaccine Revenue by Region
  2. 7.1.1 Global Multivalent Oral Rotavirus Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Multivalent Oral Rotavirus Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Multivalent Oral Rotavirus Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Multivalent Oral Rotavirus Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Multivalent Oral Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Multivalent Oral Rotavirus Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Multivalent Oral Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Multivalent Oral Rotavirus Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Multivalent Oral Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Serum Institute of India
  2. 8.1.1 Serum Institute of India Company Information
  3. 8.1.2 Serum Institute of India Business Overview
  4. 8.1.3 Serum Institute of India Multivalent Oral Rotavirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Serum Institute of India Multivalent Oral Rotavirus Vaccine Product Portfolio
  6. 8.1.5 Serum Institute of India Recent Developments
  7. 8.2 Lanzhou Institute of Biological Products
  8. 8.2.1 Lanzhou Institute of Biological Products Company Information
  9. 8.2.2 Lanzhou Institute of Biological Products Business Overview
  10. 8.2.3 Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Product Portfolio
  12. 8.2.5 Lanzhou Institute of Biological Products Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Multivalent Oral Rotavirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Multivalent Oral Rotavirus Vaccine Product Portfolio
  18. 8.3.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Multivalent Oral Rotavirus Vaccine Value Chain Analysis
  2. 9.1.1 Multivalent Oral Rotavirus Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Multivalent Oral Rotavirus Vaccine Production Mode & Process
  6. 9.2 Multivalent Oral Rotavirus Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Multivalent Oral Rotavirus Vaccine Distributors
  9. 9.2.3 Multivalent Oral Rotavirus Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst